[1] Latouche GN, Daniel HM, Lee OC, et al. Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species[J]. J Clin Microbiol, 1997, 35(12):3171-3180. [2] Sullivan DJ, Henman MC, Moran GP,et al. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species[J]. J Med Microbiol, 1996, 44(6):399-408. [3] Ciardo DE, Schar G, Bottger EC,et al. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts[J]. J Clin Microbiol, 2006, 44(1):77-84. [4] Nilsson RH, Kristiansson E, Ryberg M, et al. Intraspecific ITS variability in the kingdom fungi as expressed in the international sequence databases and its implications for molecular species identification[J]. Evol Bioinform Online, 2008, 4(26):193-201. [5] Lachance MA, Daniel HM, Meyer W, et al. The D1/D2 domain of the large-subunit rDNA of the yeast species Clavispora lusitaniae is unusually polymorphic[J]. FEMS Yeast Res,2003, 4(3):253-258. [6] Tavanti A, Davidson AD, Gow NA, et al.Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III[J]. J Clin Microbiol,2005, 43(1):284-292. [7] Vaughan-Martini A, Kurtzman CP, Meyer SA, et al. Two new species in the Pichia guilliermondii clade:Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov[J]. FEMS Yeast Res ,2005, 5(4-5):463-469. [8] Vermitsky JP, Self MJ, Chadwick SG, et al.Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection[J]. J Clin Microbiol ,2008, 46(4):1501-1503. [9] Richter SS, Galask RP, Messer SA, et al. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.[J] J Clin Microbiol ,2005, 43(5):2155-2162. [10] Spinillo A, Capuzzo E, Gulminetti R, et al. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species[J]. Am J Obstet Gynecol,1997, 176(1 Pt 1):138-141. [11] Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003[J]. J Clin Microbiol ,2005, 43(4):1829-1835. [12] Miranda LN, van der Heijden IM, et al.Candida colonisation as a source for candidaemia[J]. J Hosp Infect ,2009, 72(1):9-16. [13] Nakamura T, Takahashi H: Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia[J]. J Infect Chemother ,2006, 12(3):132-138. [14] Pfaller MA, Diekema DJ, Gibbs DL, et al.Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis:a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005[J]. J Clin Microbiol, 2008, 46(3):842-849. [15] Chen YC,Lin YH,Chen KW,et al.Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan. [J].Diagn Microbiol Infect Dis.2010, 68(3): p. 284-292. [16] Orsi CF, Colombari B, Blasi E.Candida metapsilosis as the least virulent member of the 'C.parapsilosis' complex[J]. Med Mycol, 48(8):1024-1033. |